Live Nation Entertainment (LYV) is trading higher as the market digests the final-stage posture of the antitrust trial brought by 34 states over Live Nation and Ticketmaster’s alleged monopoly conduct. The jury began deliberations and finished its first day without a verdict, then was set to resume deliberations Monday, April 13, 2026—keeping the near-term catalyst squarely on the legal outcome and any read-through on remedies. (apnews.com)

The trial outcome can affect valuation by changing perceived long-term cash-flow risk tied to ticketing fees, venue relationships, and contracting practices. Investors have already seen one major uncertainty reduced after Live Nation reached a settlement with the U.S. Justice Department in March 2026, shifting attention to whether the remaining states’ claims produce incremental remedies or damages beyond what was agreed with the federal government. (cbsnews.com)

The next inflection is the jury’s verdict and any immediate post-verdict motions or remedy proceedings. Separately, Wall Street has been updating targets and outlook assumptions following the DOJ settlement framework and 2026 operating expectations, which can amplify share moves around trial headlines as investors recalibrate both legal-risk and growth narratives. (investing.com)